Anserine Labs, Inc. research brief
CIK 2083708
Generated Nov. 18, 2026, 11:31 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: LONDON United Kingdom. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 28, 2025 · D · 0001231919-25-000168 · Source evidence
Reported offering amount: 3500000 USD. Reported amount sold: 3439997 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Anserine Labs, Inc. research brief,” CIK 2083708, retrieved Nov. 18, 2026, 11:31 p.m.. Cite the specific accessions used. No amounts have been summed.